Financials IRRAS AB

Equities

IRRAS

SE0008321202

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 07:59:43 2023-11-03 am EDT 5-day change 1st Jan Change
0.1604 SEK -1.11% Intraday chart for IRRAS AB -.--% -.--%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024
Capitalization 1 814.2 674.3 553.4 310 374.4 181.7 181.7
Enterprise Value (EV) 1 814.2 646.8 417.9 254.1 374.4 392.5 439.6
P/E ratio -5.81 x -4.17 x -3.39 x -2.06 x -0.91 x -0.13 x -0.43 x
Yield - - - - - - -
Capitalization / Revenue 136 x 127 x 74.8 x 13.8 x 9.36 x 1.1 x 0.73 x
EV / Revenue 136 x 122 x 56.5 x 11.3 x 9.36 x 2.38 x 1.77 x
EV / EBITDA -6.02 x -4.66 x -3.54 x -2.12 x -2.47 x -4.69 x -42.4 x
EV / FCF - -3,838,817 x -3,128,738 x -1,938,041 x - - -
FCF Yield - -0% -0% -0% - - -
Price to Book - 5.13 x 3.04 x 2.53 x - -0.09 x -0.07 x
Nbr of stocks (in thousands) 24,018 28,818 66,281 79,481 794,813 1,133,078 1,133,078
Reference price 2 33.90 23.40 8.350 3.900 0.4710 0.1604 0.1604
Announcement Date 2/14/19 2/14/20 2/16/21 2/16/22 2/16/23 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024
Net sales 1 6 5.3 7.4 22.4 40 165 248.5
EBITDA 1 -135.2 -138.9 -118 -119.7 -151.7 -83.63 -10.36
EBIT 1 - -151.5 -134.3 -136.5 -168.1 -101.7 -30.16
Operating Margin - -2,858.49% -1,814.86% -609.38% -420.25% -61.61% -12.14%
Earnings before Tax (EBT) 1 - -151.1 -135.9 -136.3 -166.6 -101.2 -29.66
Net income 1 - -151.1 -135.9 -136.3 -166.6 -101.2 -29.66
Net margin - -2,850.94% -1,836.49% -608.48% -416.5% -61.31% -11.93%
EPS 2 -5.830 -5.610 -2.460 -1.890 -0.5200 -1.270 -0.3700
Free Cash Flow - -168.5 -133.6 -131.1 - - -
FCF margin - -3,179.25% -1,805.07% -585.27% - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - - - - -
Announcement Date 2/14/19 2/14/20 2/16/21 2/16/22 2/16/23 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 4 5.1 6.1 7.2 8.6 9.7 11 10.6 11.2 10.3
EBITDA -34.8 - - - - - - - - -
EBIT 1 -39.3 - -27 -43.5 -33.7 -35.8 -51.9 -46.7 -59.2 -40.5
Operating Margin -982.5% - -442.62% -604.17% -391.86% -369.07% -471.82% -440.57% -528.57% -393.2%
Earnings before Tax (EBT) -38.8 -27.1 -26.9 -43.4 -33.3 -36.9 - - - -
Net income -38.8 - -26.9 -43.4 -33.3 -36.9 - - - -
Net margin -970% - -440.98% -602.78% -387.21% -380.41% - - - -
EPS -0.5900 - - - - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 5/4/21 8/26/21 11/9/21 2/16/22 4/27/22 7/22/22 11/10/22 2/16/23 5/17/23 8/4/23
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024
Net Debt 1 - - - - - 211 258
Net Cash position 1 - 27.5 136 55.9 - - -
Leverage (Debt/EBITDA) - - - - - -2.52 x -24.89 x
Free Cash Flow - -169 -134 -131 - - -
ROE (net income / shareholders' equity) - -95.7% -86.6% -92.7% - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - 4.560 2.750 1.540 - -1.770 -2.150
Cash Flow per Share - - - - - - -
Capex 1 0.5 0.6 0.88 0.6 - 1.65 2.49
Capex / Sales 8.33% 11.32% 11.92% 2.68% - 1% 1%
Announcement Date 2/14/19 2/14/20 2/16/21 2/16/22 2/16/23 - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Quarterly revenue - Rate of surprise